GLP-1 S (3mg) × 30 Tablets is an oral research peptide formulation being studied for its potential roles in appetite regulation, satiety signaling, and metabolic pathways.
-
GLP-1–related signaling is of interest in research exploring mechanisms that may influence appetite, fullness, and caloric intake.
-
Studies are examining potential effects on fat metabolism, energy balance, and body composition.
-
Ongoing research also investigates glucose-related pathways, including insulin sensitivity and glycemic control.
For research use only. Not approved for human consumption. Sold in tablet form.
All ingredients are synthesized to ≥99% purity, manufactured in the USA in GMP-compliant facilities, and third-party tested to ensure quality, consistency, and transparency.
